Circular RNA Fbxl5 Regulates Cardiomyocyte Apoptosis During Ischemia Reperfusion Injury via Sponging microRNA-146a

References

• Amani H, Habibey R, Hajmiresmail SJ, Latifi S, Pazoki-Toroudi H, Akhavan O. Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. J Mater Chem B. 2017;5(48):9452–9476. doi:10.1039/C7TB01689A
   PubMed Web of Science ®Google Scholar
• Ibanez B, Heusch G, Ovize M. Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65(14):1454–1471. doi:10.1016/j.jacc.2015.02.032
   PubMed Web of Science ®Google Scholar
• Heusch G. Critical Issues for the Translation of Cardioprotection. Circ Res. 2017;120(9):1477–1486. doi:10.1161/CIRCRESAHA.117.310820
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Sun HS, Tsai SJ, Circular RNA. New member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–1141. doi:10.1177/1535370217708978
   PubMed Web of Science ®Google Scholar
• Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17(4):205–211. doi:10.1038/nrm.2015.32
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi:10.1038/nature11928
   PubMed Web of Science ®Google Scholar
• Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016;37(33):2602–2611. doi:10.1093/eurheartj/ehv713
   PubMed Web of Science ®Google Scholar
• Wang K, Gan TY, Li N, et al. Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression. Cell Death Differ. 2017;24(6):1111–1120. doi:10.1038/cdd.2017.61
   PubMed Web of Science ®Google Scholar
• Zhou LY, Zhai M, Huang Y, et al. The circular RNA ACR attenuates myocardial ischemia/reperfusion injury by suppressing autophagy via modulation of the Pink1/ FAM65B pathway. Cell Death Differ. 2018;26(7):1299–1315. doi:10.1038/s41418-018-0206-4
   PubMed Web of Science ®Google Scholar
• Cai L, Qi B, Wu X, et al. Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b. J Mol Cell Cardiol. 2019;130:10–22. doi:10.1016/j.yjmcc.2019.03.007
   PubMed Web of Science ®Google Scholar
• Geng HH, Li R, Su YM, et al. The Circular RNA Cdr1as Promotes Myocardial Infarction by Mediating the Regulation of miR-7a on Its Target Genes Expression. PLoS One. 2016;11(3):e0151753. doi:10.1371/journal.pone.0151753
   PubMed Web of Science ®Google Scholar
• Zhang T, Ma Y, Gao L, et al. MicroRNA-146a protects against myocardial ischaemia reperfusion injury by targeting Med1. Cell Mol Biol Lett. 2019;24:62. doi:10.1186/s11658-019-0186-5
   PubMed Web of Science ®Google Scholar
• National Research Council Committee for the Update of the Guide for the C, Use of Laboratory A. The National Academies Collection: Reports Funded by National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US)Copyright © 2011, National Academy of Sciences; 2011.
   Google Scholar
• Percie N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410
   PubMed Web of Science ®Google Scholar
• Carroll KJ, Makarewich CA, McAnally J, et al. A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9. Proc Natl Acad Sci U S A. 2016;113(2):338–343. doi:10.1073/pnas.1523918113
   PubMed Web of Science ®Google Scholar
• Tan WQ, Wang K, Lv DY, Li PF. Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J Biol Chem. 2008;283(44):29730–29739. doi:10.1074/jbc.M805514200
   PubMed Web of Science ®Google Scholar
• Li PF, Li J, Müller EC, Otto A, Dietz R, von Harsdorf R. Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. Mol Cell. 2002;10(2):247–258. doi:10.1016/S1097-2765(02)00600-7
   PubMed Web of Science ®Google Scholar
• Hansen TB, Wiklund ED, Bramsen JB, et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 2011;30(21):4414–4422. doi:10.1038/emboj.2011.359
   PubMed Web of Science ®Google Scholar
• Lorenzen J, Kumarswamy R, Dangwal S, Thum T. MicroRNAs in diabetes and diabetes-associated complications. RNA Biol. 2012;9(6):820–827. doi:10.4161/rna.20162
   PubMed Web of Science ®Google Scholar
• Wang X, Ha T, Liu L, et al. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res. 2013;97(3):432–442. doi:10.1093/cvr/cvs356
   PubMed Web of Science ®Google Scholar
• Zhang W, Shao M, He X, Wang B, Li Y, Guo X. Overexpression of microRNA-146 protects against oxygen-glucose deprivation/recovery-induced cardiomyocyte apoptosis by inhibiting the NF-κB/TNF-α signaling pathway. Mol Med Rep. 2018;17(1):1913–1918. doi:10.3892/mmr.2017.8073
   PubMed Web of Science ®Google Scholar
• Liu X, Wang M, Li Q, Liu W, Song Q, Jiang H. CircRNA ACAP2 induces myocardial apoptosis after myocardial infarction by sponging miR-29. Minerva Med. 2020;1:45.
   Google Scholar
• Si X, Zheng H, Wei G, et al. circRNA Hipk3 Induces Cardiac Regeneration after Myocardial Infarction in Mice by Binding to Notch1 and miR-133a. Mol Ther Nucleic Acids. 2020;21:636–655. doi:10.1016/j.omtn.2020.06.024
   PubMedGoogle Scholar
• Garikipati VNS, Verma SK, Cheng Z, et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis. Nat Commun. 2019;10(1):4317. doi:10.1038/s41467-019-11777-7
   PubMed Web of Science ®Google Scholar
• Takov K, He Z, Johnston HE, et al. Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential. Basic Res Cardiol. 2020;115(3):26. doi:10.1007/s00395-020-0785-3
   PubMed Web of Science ®Google Scholar
• Geng T, Song ZY, Xing JX, Wang BX, Dai SP, Xu ZS. Exosome Derived from Coronary Serum of Patients with Myocardial Infarction Promotes Angiogenesis Through the miRNA-143/IGF-IR Pathway. Int J Nanomedicine. 2020;15:2647–2658. doi:10.2147/IJN.S242908
   PubMed Web of Science ®Google Scholar
• Sayed N, Tambe P, Kumar P, Jadhav S, Paknikar KM, Gajbhiye V. miRNA transfection via poly(amidoamine)-based delivery vector prevents hypoxia/reperfusion-induced cardiomyocyte apoptosis. Nanomedicine. 2020;15(2):163–181. doi:10.2217/nnm-2019-0363
   PubMed Web of Science ®Google Scholar
• Zhou H, Shan Y, Tong F, et al. Resveratrol Nanoparticle Complex: potential Therapeutic Applications in Myocardial Ischemia Reperfusion Injury. J Biomed Nanotechnol. 2020;16(3):382–389. doi:10.1166/jbn.2020.2900
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzás EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2:54.
   Google Scholar
• Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8(2):129–138. doi:10.1038/nrd2742
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chan HF, Leong KW. Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev. 2013;65(1):104–120. doi:10.1016/j.addr.2012.10.003
   PubMed Web of Science ®Google Scholar
• Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15(8):541–555. doi:10.1038/nrg3763
   PubMed Web of Science ®Google Scholar
• Li J, Wu C, Wang W, et al. Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference. Proc Natl Acad Sci U S A. 2018;115(12):E2696–e705. doi:10.1073/pnas.1719565115
   PubMed Web of Science ®Google Scholar